SLC30A8 and type 2 diabetes mellitus: Interestingly, studies in humans have shown that ZnT8 loss-of-function mutants are associated with increased insulin secretion capacity and lower risk of developing type 2 diabetes (Flannick et al., 2014; Dwivedi et al., 2019).